Depression among adults with diabetes

Prevalence, impact, and treatment options

Mary de Groot, Michael Kushnick, Todd Doyle, Jennifer Merrill, Mark McGlynn, Jay Shubrook, Frank Schwartz

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Patients with type 1 or type 2 diabetes are two times more likely to experience depression than their peers without diabetes. Comorbid depression results in deleterious effects on glycemic control, worsened diabetes complications, functional disability, and premature mortality. Once identified, depression can be effectively treated with antidepressant medications, psychotherapy, or a combination of both. Patients and providers should monitor depressive symptoms to identify their recurrence and work collaboratively to address barriers to care that exist in both urban and rural areas.

Original languageEnglish
Pages (from-to)15-18
Number of pages4
JournalDiabetes Spectrum
Volume23
Issue number1
DOIs
StatePublished - Dec 2010

Fingerprint

Depression
Premature Mortality
Diabetes Complications
Therapeutics
Psychotherapy
Type 2 Diabetes Mellitus
Antidepressive Agents
Recurrence

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

de Groot, M., Kushnick, M., Doyle, T., Merrill, J., McGlynn, M., Shubrook, J., & Schwartz, F. (2010). Depression among adults with diabetes: Prevalence, impact, and treatment options. Diabetes Spectrum, 23(1), 15-18. https://doi.org/10.2337/diaspect.23.1.15

Depression among adults with diabetes : Prevalence, impact, and treatment options. / de Groot, Mary; Kushnick, Michael; Doyle, Todd; Merrill, Jennifer; McGlynn, Mark; Shubrook, Jay; Schwartz, Frank.

In: Diabetes Spectrum, Vol. 23, No. 1, 12.2010, p. 15-18.

Research output: Contribution to journalArticle

de Groot, M, Kushnick, M, Doyle, T, Merrill, J, McGlynn, M, Shubrook, J & Schwartz, F 2010, 'Depression among adults with diabetes: Prevalence, impact, and treatment options', Diabetes Spectrum, vol. 23, no. 1, pp. 15-18. https://doi.org/10.2337/diaspect.23.1.15
de Groot, Mary ; Kushnick, Michael ; Doyle, Todd ; Merrill, Jennifer ; McGlynn, Mark ; Shubrook, Jay ; Schwartz, Frank. / Depression among adults with diabetes : Prevalence, impact, and treatment options. In: Diabetes Spectrum. 2010 ; Vol. 23, No. 1. pp. 15-18.
@article{d8de49b12c12456e880ccdd5e130729a,
title = "Depression among adults with diabetes: Prevalence, impact, and treatment options",
abstract = "Patients with type 1 or type 2 diabetes are two times more likely to experience depression than their peers without diabetes. Comorbid depression results in deleterious effects on glycemic control, worsened diabetes complications, functional disability, and premature mortality. Once identified, depression can be effectively treated with antidepressant medications, psychotherapy, or a combination of both. Patients and providers should monitor depressive symptoms to identify their recurrence and work collaboratively to address barriers to care that exist in both urban and rural areas.",
author = "{de Groot}, Mary and Michael Kushnick and Todd Doyle and Jennifer Merrill and Mark McGlynn and Jay Shubrook and Frank Schwartz",
year = "2010",
month = "12",
doi = "10.2337/diaspect.23.1.15",
language = "English",
volume = "23",
pages = "15--18",
journal = "Diabetes Spectrum",
issn = "1040-9165",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Depression among adults with diabetes

T2 - Prevalence, impact, and treatment options

AU - de Groot, Mary

AU - Kushnick, Michael

AU - Doyle, Todd

AU - Merrill, Jennifer

AU - McGlynn, Mark

AU - Shubrook, Jay

AU - Schwartz, Frank

PY - 2010/12

Y1 - 2010/12

N2 - Patients with type 1 or type 2 diabetes are two times more likely to experience depression than their peers without diabetes. Comorbid depression results in deleterious effects on glycemic control, worsened diabetes complications, functional disability, and premature mortality. Once identified, depression can be effectively treated with antidepressant medications, psychotherapy, or a combination of both. Patients and providers should monitor depressive symptoms to identify their recurrence and work collaboratively to address barriers to care that exist in both urban and rural areas.

AB - Patients with type 1 or type 2 diabetes are two times more likely to experience depression than their peers without diabetes. Comorbid depression results in deleterious effects on glycemic control, worsened diabetes complications, functional disability, and premature mortality. Once identified, depression can be effectively treated with antidepressant medications, psychotherapy, or a combination of both. Patients and providers should monitor depressive symptoms to identify their recurrence and work collaboratively to address barriers to care that exist in both urban and rural areas.

UR - http://www.scopus.com/inward/record.url?scp=77949794847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949794847&partnerID=8YFLogxK

U2 - 10.2337/diaspect.23.1.15

DO - 10.2337/diaspect.23.1.15

M3 - Article

VL - 23

SP - 15

EP - 18

JO - Diabetes Spectrum

JF - Diabetes Spectrum

SN - 1040-9165

IS - 1

ER -